within Pharmacolibrary.Drugs.ATC.S;

model S03CA06
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 1.944444444444445e-06,
    adminDuration  = 600,
    adminMass      = 0.5 / 1000000,
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>BetamethasoneAndAntiinfectives</td></tr><tr><td>ATC code:</td><td>S03CA06</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Combination drug containing betamethasone, a potent synthetic glucocorticoid corticosteroid with anti-inflammatory and immunosuppressive properties, and antiinfectives, typically for topical ophthalmic use to treat eye infections with an inflammatory component. Not widely approved as a fixed combination in all regions today, but used in some countries.</p><h4>Pharmacokinetics</h4><p>No published population pharmacokinetic studies of the fixed combination of betamethasone with antiinfectives (S03CA06) have been identified. Pharmacokinetic parameters estimated based on topical ophthalmic betamethasone data in healthy adults.</p><h4>References</h4><ol><li><p>Lim, SY, et al., &amp; Heard, CM (2020). Mucoadhesive thin films for the simultaneous delivery of microbicide and anti-inflammatory drugs in the treatment of periodontal diseases. <i>International journal of pharmaceutics</i> 573 118860â€“None. DOI:<a href=\"https://doi.org/10.1016/j.ijpharm.2019.118860\">10.1016/j.ijpharm.2019.118860</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31759104/\">https://pubmed.ncbi.nlm.nih.gov/31759104</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>"
  ));
end S03CA06;
